212 related articles for article (PubMed ID: 31343460)
21. D2-like receptor agonist synergizes the μ-opioid agonist spinal antinociception in nociceptive, inflammatory and neuropathic models of pain in the rat.
Mercado-Reyes J; Almanza A; Segura-Chama P; Pellicer F; Mercado F
Eur J Pharmacol; 2019 Jun; 853():56-64. PubMed ID: 30876975
[TBL] [Abstract][Full Text] [Related]
22. Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia.
Gaveriaux-Ruff C; Nozaki C; Nadal X; Hever XC; Weibel R; Matifas A; Reiss D; Filliol D; Nassar MA; Wood JN; Maldonado R; Kieffer BL
Pain; 2011 Jun; 152(6):1238-1248. PubMed ID: 21295407
[TBL] [Abstract][Full Text] [Related]
23. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy.
Stone LS; MacMillan LB; Kitto KF; Limbird LE; Wilcox GL
J Neurosci; 1997 Sep; 17(18):7157-65. PubMed ID: 9278550
[TBL] [Abstract][Full Text] [Related]
24. Moxonidine, a selective imidazoline-alpha2 -adrenergic receptor agonist, produces spinal synergistic antihyperalgesia with morphine in nerve-injured mice.
Fairbanks CA; Nguyen HO; Grocholski BM; Wilcox GL
Anesthesiology; 2000 Sep; 93(3):765-73. PubMed ID: 10969310
[TBL] [Abstract][Full Text] [Related]
25. Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents.
Beaudry H; Proteau-Gagné A; Li S; Dory Y; Chavkin C; Gendron L
Neuroscience; 2009 Jun; 161(2):381-91. PubMed ID: 19328839
[TBL] [Abstract][Full Text] [Related]
26. Antinociceptive Interactions between the Imidazoline I2 Receptor Agonist 2-BFI and Opioids in Rats: Role of Efficacy at the μ-Opioid Receptor.
Siemian JN; Obeng S; Zhang Y; Zhang Y; Li JX
J Pharmacol Exp Ther; 2016 Jun; 357(3):509-19. PubMed ID: 27056847
[TBL] [Abstract][Full Text] [Related]
27. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia.
Zhou L; Zhang Q; Stein C; Schäfer M
J Pharmacol Exp Ther; 1998 Aug; 286(2):1000-6. PubMed ID: 9694961
[TBL] [Abstract][Full Text] [Related]
28. The delta-opioid receptor is sufficient, but not necessary, for spinal opioid-adrenergic analgesic synergy.
Chabot-Doré AJ; Millecamps M; Stone LS
J Pharmacol Exp Ther; 2013 Dec; 347(3):773-80. PubMed ID: 24039246
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the antinociceptive and adverse effects of the mu-opioid agonist morphine and the delta-opioid agonist SNC80.
Gallantine EL; Meert TF
Basic Clin Pharmacol Toxicol; 2005 Jul; 97(1):39-51. PubMed ID: 15943758
[TBL] [Abstract][Full Text] [Related]
30. Nerve injury induces a tonic bilateral mu-opioid receptor-mediated inhibitory effect on mechanical allodynia in mice.
Mansikka H; Zhao C; Sheth RN; Sora I; Uhl G; Raja SN
Anesthesiology; 2004 Apr; 100(4):912-21. PubMed ID: 15087627
[TBL] [Abstract][Full Text] [Related]
31. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia.
Sun J; Chen SR; Chen H; Pan HL
J Physiol; 2019 Mar; 597(6):1661-1675. PubMed ID: 30578671
[TBL] [Abstract][Full Text] [Related]
32. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
33. Antipruritic and antihyperalgesic actions of loperamide and analogs.
DeHaven-Hudkins DL; Cowan A; Cortes Burgos L; Daubert JD; Cassel JA; DeHaven RN; Kehner GB; Kumar V
Life Sci; 2002 Oct; 71(23):2787-96. PubMed ID: 12383884
[TBL] [Abstract][Full Text] [Related]
34. Involvement of nitric oxide in the inhibition of bone cancer-induced hyperalgesia through the activation of peripheral opioid receptors in mice.
Menéndez L; Juárez L; García V; Hidalgo A; Baamonde A
Neuropharmacology; 2007 Jul; 53(1):71-80. PubMed ID: 17543351
[TBL] [Abstract][Full Text] [Related]
35. The efficacy of Dynorphin fragments at the κ, μ and δ opioid receptor in transfected HEK cells and in an animal model of unilateral peripheral inflammation.
Morgan M; Heffernan A; Benhabib F; Wagner S; Hewavitharana AK; Shaw PN; Cabot PJ
Peptides; 2017 Mar; 89():9-16. PubMed ID: 28049031
[TBL] [Abstract][Full Text] [Related]
36. Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.
Beaudry H; Gendron L; Morón JA
Eur J Neurosci; 2015 Apr; 41(7):901--7. PubMed ID: 25639561
[TBL] [Abstract][Full Text] [Related]
37. S1RA, a selective sigma-1 receptor antagonist, inhibits inflammatory pain in the carrageenan and complete Freund's adjuvant models in mice.
Gris G; Merlos M; Vela JM; Zamanillo D; Portillo-Salido E
Behav Pharmacol; 2014 Jun; 25(3):226-35. PubMed ID: 24776490
[TBL] [Abstract][Full Text] [Related]
38. Effects of loperamide on mechanical allodynia induced by herpes simplex virus type-1 in mice.
Sasaki A; Nakashima Y; Takasaki I; Andoh T; Shiraki K; Kuraishi Y
J Pharmacol Sci; 2007 Jul; 104(3):218-24. PubMed ID: 17598951
[TBL] [Abstract][Full Text] [Related]
39. Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia.
Auh QS; Chun YH; Melemedjian OK; Zhang Y; Ro JY
Brain Res Bull; 2016 Jul; 125():211-7. PubMed ID: 27450703
[TBL] [Abstract][Full Text] [Related]
40. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
